北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 内分泌科  > 期刊论文
学科主题: 临床医学
题名:
Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes
作者: Gao, Hong-Wei; Xie, Chao; Wang, Hai-Ning; Lin, Yu-Jing; Hong, Tian-Pei
关键词: nateglinide ; acarbose ; free fatty acids ; asymmetric dimethylarginine
刊名: ACTA PHARMACOLOGICA SINICA
发表日期: 2007-04-01
DOI: 10.1111/j.1745-7254.2007.00534.x
卷: 28, 期:4, 页:534-539
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
研究领域[WOS]: Chemistry ; Pharmacology & Pharmacy
关键词[WOS]: NITRIC-OXIDE SYNTHASE ; ASYMMETRIC DIMETHYLARGININE CONCENTRATIONS ; INSULIN-RESISTANCE ; ENDOTHELIAL DYSFUNCTION ; GLUCOSE-METABOLISM ; PLASMA-CONCENTRATIONS ; ENDOGENOUS INHIBITOR ; RISK-FACTORS ; FATTY-ACIDS ; SECRETION
英文摘要:

Aim: To investigate the acute and chronic effects of nateglinide versus acarbose on plasma asymmetric dimethylarginine (ADMA) levels and lipid profiles in patients with newly-diagnosed type 2 diabetes. Methods: A crossover trial of nateglinide and acarbose was conducted on 16 drug-naive patients with newly-diagnosed type 2 diabetes during a total period of 9 weeks. Plasma glucose, serum insulin, free fatty acids (FFA), lipids and lipoproteins, and plasma ADMA were measured. Results: The efficiencies of a single dose of nateglinide (120 mg) and acarbose (50 mg) for lowering postprandial hyperglycemia were similar. Compared to acarbose, nateglinide significantly increased postprandial insulin release after a standard meal test in patients with type 2 diabetes. Nateglinide acutely decreased postprandial 120 min FFA concentrations and 240 min ADMA levels more significantly than acarbose. The fasting high-density lipoprotein cholesterol level increased and the low-density lipoprotein cholesterol level decreased significantly, but the fasting levels of triglycerides, total cholesterol, and ADMA were unchanged after 4 weeks of treatment with nateglinide. Acarbose did not affect fasting lipid profiles or the ADMA levels after 4 weeks of treatment. Conclusion: These results suggest that the reduction of postprandial FFA and ADMA concentrations induced by nateglinide may be associated with the partial restoration of early-phase insulin secretion and may impart a cardiovascular advantage in comparison with acarbose.

语种: 英语
WOS记录号: WOS:000245224700009
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/61996
Appears in Collections:北京大学第三临床医学院_内分泌科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: Peking Univ, Hosp 3, Dept Endocrinol, Beijing 100083, Peoples R China

Recommended Citation:
Gao, Hong-Wei,Xie, Chao,Wang, Hai-Ning,et al. Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes[J]. ACTA PHARMACOLOGICA SINICA,2007,28(4):534-539.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Gao, Hong-Wei]'s Articles
[Xie, Chao]'s Articles
[Wang, Hai-Ning]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Gao, Hong-Wei]‘s Articles
[Xie, Chao]‘s Articles
[Wang, Hai-Ning]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace